MedPath

Shanxi Bethune Hospital

Ownership
Private
Employees
-
Market Cap
-
Website

Hybrid Closed-Loop in Diabetes Post-Kidney Transplant: A Randomized Trial

Not Applicable
Recruiting
Conditions
Diabetes Mellitus Patients With Kidney Transplantation
First Posted Date
2025-05-08
Last Posted Date
2025-05-08
Lead Sponsor
Shanxi Bethune Hospital
Target Recruit Count
30
Registration Number
NCT06962410
Locations
🇨🇳

Shanxi Bethune Hospital, Taiyuan, Shanxi, China

Hybrid Closed-Loop System in LADA Patients: A Randomized Trial

Not Applicable
Recruiting
Conditions
Latent Autoimmune Diabetes in Adults (LADA)
First Posted Date
2025-04-24
Last Posted Date
2025-04-24
Lead Sponsor
Shanxi Bethune Hospital
Target Recruit Count
50
Registration Number
NCT06941675
Locations
🇨🇳

Shanxi Bethune Hospital, Taiyuan, Shanxi, China

Hybrid Closed-Loop System in Neurosurgical Perioperative Hyperglycemia: An Open RCT

Not Applicable
Recruiting
Conditions
T2DM Patients With Traumatic Brain Injury
First Posted Date
2025-04-03
Last Posted Date
2025-04-23
Lead Sponsor
Shanxi Bethune Hospital
Target Recruit Count
40
Registration Number
NCT06909071
Locations
🇨🇳

Shanxi Bethune Hospital, Taiyuan, Shanxi, China

CD30 CAR-T in the Treatment of CD30 Positive Relapsed/Refractory Lymphoma

Not Applicable
Recruiting
Conditions
Lymphoma, B-Cell
Interventions
Drug: chimeric antigen receptor gene modified T cells
First Posted Date
2025-02-27
Last Posted Date
2025-02-27
Lead Sponsor
Shanxi Bethune Hospital
Target Recruit Count
15
Registration Number
NCT06850285
Locations
🇨🇳

Shanxi Bethune Hospital, Taiyuan, Shangxi, China

A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors

Not Applicable
Recruiting
Conditions
Acute Lymphocytic Leukemia
Lymphoma,Non-Hodgkin
Relapsed Refractory Multiple Myeloma
Interventions
Drug: chimeric antigen receptor gene modified T cells
First Posted Date
2025-01-20
Last Posted Date
2025-01-20
Lead Sponsor
Shanxi Bethune Hospital
Target Recruit Count
45
Registration Number
NCT06783816
Locations
🇨🇳

Shanxi Bethune Hospital, Taiyuan, Shanxi, China

Sugammadex on Laparoscopic Bariatric Surgery

Not Applicable
Not yet recruiting
Conditions
Laparoscopic Bariatric Surgery
Sugammadex
Interventions
First Posted Date
2024-11-07
Last Posted Date
2024-11-07
Lead Sponsor
Shanxi Bethune Hospital
Target Recruit Count
60
Registration Number
NCT06678451

Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study

Not Applicable
Recruiting
Conditions
Aplastic Anemias
First Posted Date
2024-10-21
Last Posted Date
2024-10-21
Lead Sponsor
Shanxi Bethune Hospital
Target Recruit Count
110
Registration Number
NCT06650553
Locations
🇨🇳

Shanxi Bethune Hospital, Taiyuan, Shanxi, China

Thoracic Paravertebral Block in Daytime Laparoscopic Partial Adrenalectomy

Not Applicable
Recruiting
Conditions
Laparoscopic Adrenalectomy
Day Surgery
Interventions
Procedure: thoracic paravertebral block
First Posted Date
2024-08-22
Last Posted Date
2024-10-31
Lead Sponsor
Shanxi Bethune Hospital
Target Recruit Count
80
Registration Number
NCT06566521
Locations
🇨🇳

Shanxi Bethune Hospital, Taiyuan, Shanxi, China

Clinical Study of Reduced-dose Pomalidomide and Cyclophosphamide Combined With Dexamethasone in the Treatment of Patients With Debilitating RRMM

Phase 2
Recruiting
Conditions
Multiple Myeloma in Relapse
Interventions
First Posted Date
2024-02-13
Last Posted Date
2024-02-13
Lead Sponsor
Shanxi Bethune Hospital
Target Recruit Count
43
Registration Number
NCT06255847
Locations
🇨🇳

ShanxiBethuneH, Taiyuan, Shanxi, China

JY231(Internal Clinical Drug Code) Injection for the Treatment of Refractory Autoimmune Diseases

Early Phase 1
Not yet recruiting
Conditions
Autoimmune Diseases
Interventions
Genetic: JY231
First Posted Date
2024-02-06
Last Posted Date
2024-02-06
Lead Sponsor
Shanxi Bethune Hospital
Target Recruit Count
20
Registration Number
NCT06243159
Locations
🇨🇳

Shanxi Bethune Hospital, Taiyuan, Shanxi, China

© Copyright 2025. All Rights Reserved by MedPath